ScholarWorks@Korea University: Lee, Seung Heon

Detailed Information

Lee, Seung Heon (이승헌)

College of Medicine (Department of Medical Science)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

tuberculosis:4||Tuberculosis:4||Latent Tuberculosis:3||Tuberculin Test:3||moxifloxacin:3||multidrugresistant tuberculosis:2||latent tuberculous infection:2||Mycobacterium tuberculosis:2||tuberculin skin test:2||Nonsmall cell lung cancer:2||Biomarker:2||Immigrants:2||Oxidative stress:2||Reactive oxygen species:2||levofloxacin:2||Refugees:1||Latent Tuberculosis Infection:1||Therapeutics:1||medication event monitoring system:1||Pulmonary sarcomatoid carcinoma:1||Strains:1||contact screening:1||medication adherence:1||mass screening:1||FVC:1||Disease Outbreaks:1||Latent tuberculosis:1||drug monitoring:1||interleukin27:1||QuantiFERON test:1||Antituberculosis drugs:1||Multidrug resistant tuberculosis:1||Multiple reaction monitoring:1||Diagnosis:1||Factor XIII:1||histological type:1||squamous cell carcinoma:1||Cholecystitis:1||Adolescent:1||TB outbreaks:1||Surgery:1||Chronic bronchitis:1||Vascular endothelial growth factor:1||Acute Lung Injury:1||VentilatorInduced Lung Injury:1||lung cancer:1||prevalence:1||ERCC1:1||TB incidence:1||patient characteristics:1||Whole Genome Sequencing:1||microbial sensitivity tests:1||Digital tomosynthesis:1||Airway disease:1||Radiation dose:1||Bacterial:1||Reversion:1||Prognosis:1||Serum:1||Transglutaminase 2:1||clinical characteristics:1||Thymidylate synthase:1||Transmission:1||ICU admission:1||Asian Continental Ancestry Group:1||success rate:1||Multicenter randomized trial:1||Noninferiority:1||FEV1:1||Computed tomography:1||Procalcitonin:1||Lung diseases:1||Lymph nodes:1||Human plasma:1||Smoking:1||usual interstitial pneumonia:1||idiopathic pulmonary fibrosis:1||peripheral type:1||TBspecific mortality:1||COVID19 pandemic:1||InterferonGamma Release Tests:1||lost to followup rate:1||Treatment outcome:1||Receptor:1||Sasang constitutional medicine:1||Chest radiography:1||ChurgStrauss syndrome:1||multidrug resistance:1||Liquid chromatography (LC)tandem mass spectrometry (MS/MS):1||Respiration, Artificial:1||fluoroquinolone:1||Korea:1||risk factors:1||.:1||Shorter regimen:1||Programmed death ligand 1:1||epidermal growth factor:1||TaeEum type:1||SoEum type:1||fluoroquinolones:1||Interferongamma release assay:1||Dialysis:1||Chronic obstructive pulmonary disease:1||nonsmallcell lung carcinoma:1||chronic obstructive pulmonary disease:1||overlap syndrome:1||Morocco:1||Multidrugresistant tuberculosis:1||Linezolid:1||QuantiFERON (R) test:1||SoYang type:1||End stage renal disease:1||cycloserine:1||InterferonGamma Release Assay:1||Inflammation:1||neoplasm staging:1||Predictive marker:1||laboratory crosscontamination:1||wholegenome sequencing:1||Delamanid:1||costeffectiveness:1||Interstitial:1||Pneumonia:1||prothionamide:1||single nucleotide polymorphism:1||Respiratory Distress Syndrome, Adult:1||asthma:1||Chemotherapy:1||Pulmonary adenocarcinoma:1||strains:1||Infection:1||Infection Control:1||TB control:1||

STATISTICS: Total View :0; Today View :2,278

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE